Gemcitabine (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Gemcitabine drug offered from Actavis Pharma, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Gemcitabine |
| SUBSTANCE NAME: | GEMCITABINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-04-12 |
| END MARKETING DATE: | 0000-00-00 |
Gemcitabine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Gemcitabine from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 38(mg/mL) |
| START MARKETING DATE: | 2016-04-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 45963-623_3f6ee023-c42c-49bd-b10e-420b44d2b4e3 |
| PRODUCT NDC: | 45963-623 |
| APPLICATION NUMBER: | ANDA204549 |
Other GEMCITABINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
